Cordant, Inc. Natera, Inc. Transaction History
Cordant, Inc.
- $192 Billion
- Q1 2025
A detailed history of Cordant, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Cordant, Inc. holds 14 shares of NTRA stock, worth $2,113. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14Holding current value
$2,113% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding NTRA
# of Institutions
645Shares Held
120MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$1.86 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.02 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$1.02 Billion0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$1.01 Billion0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$669 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $14.6B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...